Skip to main content

Dr. Carl J. Danzig, M.D.

Ophthalmology (Ophthalmology Physician)

  • Medicare participating

At a glance

Years since graduation
22
In the NPI registry since
2008
Medicare patients seen, 2024
1,046

Licensed in Texas since 2009, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2004Medical school: Temple University School of Medicine
  • 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Ophthalmology Physician primary
    FL license ME109536 · TX license N2461 (first issued 2009; active)
  • Retina Specialist (Ophthalmology) Physician
    FL license ME109536

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Ophthalmology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,046
Services billed
14,492
Patients’ average age
79
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, faricimab-svoa, 0.1 mg6,06041
Imaging of retina2,2651,013
Injection of drug into eye1,144291
Established patient problem focused exam of visual system903438
Photography of the retina884723
Unclassified drugs765223
Established patient complete exam of visual system761682
Injection, aflibercept, 1 mg34485
New patient complete exam of visual system119119
Extended exam of the back part of the eye with optic nerve drawing119117

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Vabysmo (faricimab-svoa)452
Latanoprost
Other prescribers in Plantation, FL
253
Eylea (aflibercept)167
Brimonidine Tartrate
Other prescribers in Plantation, FL
116
Izervay (avacincaptad pegol sodium/pf)100
Eylea Hd (aflibercept)99
Ketorolac Tromethamine
Other prescribers in Plantation, FL
86
Prednisolone Acetate
Other prescribers in Plantation, FL
85
Dorzolamide-Timolol (dorzolamide hcl/timolol maleat)
Other prescribers in Plantation, FL
75
Dorzolamide Hcl
Other prescribers in Plantation, FL
41

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 13 companies reported 150 payments worth $150,110 in total to this clinician.

By company
Astellas Pharma US Inc$91,955
Ocular Therapeutix, Inc.$36,075
Genentech USA, Inc.$9,196
Astellas Pharma Global Development$5,155
Apellis Pharmaceuticals, Inc.$3,344
Genentech, Inc.$1,708
AbbVie Inc.$1,227
Samsung Bioepis Co., LTD.$713
By type
Compensation for services other than consulting (speaking, faculty)$78,900
Consulting Fee$57,348
Travel and Lodging$9,637
Food and Beverage$4,225

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 21, 2025Astellas Pharma US Inc
Oct 21, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Sep 30, 2025Astellas Pharma US Inc
Sep 30, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Dec 5, 2025Astellas Pharma US Inc
Dec 5, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Sep 18, 2025Astellas Pharma US Inc
Sep 18, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Oct 9, 2025Astellas Pharma US Inc
Oct 9, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Jun 7, 2025Astellas Pharma US Inc
Jun 7, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$7,200
Dec 9, 2025Astellas Pharma US Inc
Dec 9, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$7,200
Aug 21, 2025Astellas Pharma US Inc
Aug 21, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$6,000
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$5,200
All 89 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 22, 2025Astellas Pharma US Inc
Dec 22, 2025
Consulting Fee
Izervay · Ophthalmology
$2,600
Dec 10, 2025Ocular Therapeutix, Inc.
Dec 10, 2025
Consulting Fee$500
Dec 9, 2025Astellas Pharma US Inc
Dec 9, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$7,200
Dec 9, 2025Astellas Pharma US Inc
Dec 9, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Bonita Springs, FL
$221
Dec 9, 2025Astellas Pharma US Inc
Dec 9, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Bonita Springs, FL
$176
Dec 5, 2025Astellas Pharma US Inc
Dec 5, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Dec 5, 2025Astellas Pharma US Inc
Dec 5, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Chicago, IL
$331
Dec 5, 2025Astellas Pharma US Inc
Dec 5, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Chicago, IL
$264
Dec 5, 2025Astellas Pharma US Inc
Dec 5, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Chicago, IL
$179
Nov 14, 2025Astellas Pharma US Inc
Nov 14, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$1,000
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$5,200
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to New York, NY
$467
Nov 7, 2025Astellas Pharma Global Development
Nov 7, 2025
Consulting Fee
Izervay · Ophthalmology
$462
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to New York, NY
$450
Nov 7, 2025Astellas Pharma US Inc
Nov 7, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to New York, NY
$308
Oct 23, 2025Ocular Therapeutix, Inc.
Oct 23, 2025
Consulting Fee$250
Oct 21, 2025Astellas Pharma US Inc
Oct 21, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Oct 21, 2025Astellas Pharma US Inc
Oct 21, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Tuscaloosa, AL
$363
Oct 21, 2025Astellas Pharma US Inc
Oct 21, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Tuscaloosa, AL
$305
Oct 21, 2025Astellas Pharma US Inc
Oct 21, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Tuscaloosa, AL
$301
Oct 17, 2025Ocular Therapeutix, Inc.
Oct 17, 2025
Consulting Fee$500
Oct 16, 2025Genentech USA, Inc.
Oct 16, 2025
Consulting Fee
Vabysmo · Immunology and Ophthalmology
$4,275
Oct 16, 2025Genentech USA, Inc.
Oct 16, 2025
Travel and Lodging
Vabysmo · Immunology and Ophthalmology · travel to Orlando, FL · in-kind
$412
Oct 16, 2025Genentech USA, Inc.
Oct 16, 2025
Travel and Lodging
Vabysmo · Immunology and Ophthalmology · travel to Orlando, FL
$263
Oct 15, 2025Ocular Therapeutix, Inc.
Oct 15, 2025
Consulting Fee$2,000
Oct 9, 2025Astellas Pharma US Inc
Oct 9, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Oct 9, 2025Astellas Pharma US Inc
Oct 9, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to West Springfield, MA
$708
Oct 9, 2025Astellas Pharma US Inc
Oct 9, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to West Springfield, MA
$176
Oct 9, 2025Astellas Pharma US Inc
Oct 9, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to West Springfield, MA
$124
Oct 6, 2025Ocular Therapeutix, Inc.
Oct 6, 2025
Consulting Fee$1,000
Sep 30, 2025Astellas Pharma US Inc
Sep 30, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Sep 30, 2025Astellas Pharma US Inc
Sep 30, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to New Orleans, LA
$1,453
Sep 30, 2025Astellas Pharma US Inc
Sep 30, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to New Orleans, LA
$455
Sep 30, 2025Astellas Pharma US Inc
Sep 30, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to New Orleans, LA
$313
Sep 28, 2025Ocular Therapeutix, Inc.
Sep 28, 2025
Consulting Fee$500
Sep 27, 2025Ocular Therapeutix, Inc.
Sep 27, 2025
Consulting Fee$250
Sep 26, 2025AbbVie Inc.
Sep 26, 2025
Consulting Fee
OZURDEX · EYE CARE
$1,025
Sep 22, 2025Ocular Therapeutix, Inc.
Sep 22, 2025
Consulting Fee$500
Sep 21, 2025Ocular Therapeutix, Inc.
Sep 21, 2025
Consulting Fee$250
Sep 19, 2025Ocular Therapeutix, Inc.
Sep 19, 2025
Consulting Fee$500
Sep 18, 2025Astellas Pharma US Inc
Sep 18, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$8,400
Sep 18, 2025Astellas Pharma US Inc
Sep 18, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Reno, NV
$744
Sep 18, 2025Astellas Pharma US Inc
Sep 18, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Reno, NV
$310
Sep 18, 2025Astellas Pharma US Inc
Sep 18, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Reno, NV
$223
Aug 30, 2025Ocular Therapeutix, Inc.
Aug 30, 2025
Consulting Fee$1,000
Aug 29, 2025Apellis Pharmaceuticals, Inc.
Aug 29, 2025
Consulting Fee$2,838
Aug 29, 2025Apellis Pharmaceuticals, Inc.
Aug 29, 2025
Consulting Fee$363
Aug 25, 2025Ocular Therapeutix, Inc.
Aug 25, 2025
Consulting Fee$1,000
Aug 21, 2025Astellas Pharma US Inc
Aug 21, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$6,000
Aug 21, 2025Astellas Pharma US Inc
Aug 21, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Boca Raton, FL
$28.00
Aug 15, 2025Astellas Pharma US Inc
Aug 15, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$1,000
Aug 11, 2025Ocular Therapeutix, Inc.
Aug 11, 2025
Consulting Fee$1,000
Aug 1, 2025Astellas Pharma Global Development
Aug 1, 2025
Consulting Fee
Izervay · Ophthalmology
$1,846
Aug 1, 2025Ocular Therapeutix, Inc.
Aug 1, 2025
Consulting Fee$1,000
Jul 31, 2025Genentech USA, Inc.
Jul 31, 2025
Consulting Fee$3,445
Jul 31, 2025Genentech USA, Inc.
Jul 31, 2025
Travel and Lodging
travel to Long Beach, CA
$304
Jul 31, 2025Genentech USA, Inc.
Jul 31, 2025
Travel and Lodging
travel to Long Beach, CA
$16.94
Jul 15, 2025Ocular Therapeutix, Inc.
Jul 15, 2025
Consulting Fee$1,000
Jul 2, 2025Genentech, Inc.
Jul 2, 2025
Consulting Fee
Vabysmo · Immunology and Ophthalmology
$840
Jul 2, 2025Genentech, Inc.
Jul 2, 2025
Consulting Fee
Vabysmo · Immunology and Ophthalmology
$840
Jun 21, 2025Ocular Therapeutix, Inc.
Jun 21, 2025
Consulting Fee$2,500
Jun 20, 2025Ocular Therapeutix, Inc.
Jun 20, 2025
Consulting Fee$1,833
Jun 19, 2025Ocular Therapeutix, Inc.
Jun 19, 2025
Consulting Fee$2,000
Jun 18, 2025Ocular Therapeutix, Inc.
Jun 18, 2025
Consulting Fee$1,000
Jun 17, 2025Ocular Therapeutix, Inc.
Jun 17, 2025
Consulting Fee$500
Jun 12, 2025Astellas Pharma US Inc
Jun 12, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$900
Jun 7, 2025Astellas Pharma US Inc
Jun 7, 2025
Compensation for services other than consulting (speaking, faculty)
Izervay · Ophthalmology
$7,200
Jun 7, 2025Astellas Pharma US Inc
Jun 7, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Orlando, FL
$446
Jun 7, 2025Astellas Pharma US Inc
Jun 7, 2025
Travel and Lodging
Izervay · Ophthalmology · travel to Orlando, FL
$293
Jun 6, 2025Astellas Pharma Global Development
Jun 6, 2025
Consulting Fee
Izervay · Ophthalmology
$2,769
May 29, 2025Ocular Therapeutix, Inc.
May 29, 2025
Consulting Fee$1,000
May 11, 2025Ocular Therapeutix, Inc.
May 11, 2025
Consulting Fee$1,000
May 10, 2025Ocular Therapeutix, Inc.
May 10, 2025
Consulting Fee$500
May 9, 2025Ocular Therapeutix, Inc.
May 9, 2025
Consulting Fee$500
May 5, 2025Ocular Therapeutix, Inc.
May 5, 2025
Consulting Fee$1,000
Apr 27, 2025Ocular Therapeutix, Inc.
Apr 27, 2025
Consulting Fee$500
Apr 24, 2025Ocular Therapeutix, Inc.
Apr 24, 2025
Consulting Fee$500
Apr 24, 2025Ocular Therapeutix, Inc.
Apr 24, 2025
Consulting Fee$500
Apr 4, 2025Ocular Therapeutix, Inc.
Apr 4, 2025
Consulting Fee$2,000
Apr 1, 2025Ocular Therapeutix, Inc.
Apr 1, 2025
Consulting Fee$1,000
Mar 18, 2025Ocular Therapeutix, Inc.
Mar 18, 2025
Consulting Fee$1,000
Mar 3, 2025Ocular Therapeutix, Inc.
Mar 3, 2025
Consulting Fee$1,000
Feb 22, 2025Ocular Therapeutix, Inc.
Feb 22, 2025
Consulting Fee$2,500
Feb 7, 2025Ocular Therapeutix, Inc.
Feb 7, 2025
Consulting Fee$1,000
Jan 27, 2025Ocular Therapeutix, Inc.
Jan 27, 2025
Consulting Fee$1,500
Jan 20, 2025Ocular Therapeutix, Inc.
Jan 20, 2025
Consulting Fee$500
Jan 20, 2025Ocular Therapeutix, Inc.
Jan 20, 2025
Consulting Fee$250
Jan 16, 2025Samsung Bioepis Co., LTD.
Jan 16, 2025
Consulting Fee
E301 · Ophthalmology
$713

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 9 industry-funded studies in 2025, from 8 companies. The companies reported $454,879 in research payments for these studies, mostly to the institutions running them.

  • Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (axitinib Implant) in Subjects with Neovascular Age-Related Macular Degeneration
    Ocular Therapeutix, Inc.
  • A Phase 2 Randomized, double-masked, active-controlled study to evaluate efficacy and safety of two regimens of BI 771716 against pegcetacoplan in patients with geographic atrophy secondary to age-related macular dege…
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • IAMD Observational Study
    Genentech, Inc.
  • BAY 865321, Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion
    Bayer HealthCare Pharmaceuticals Inc.
  • A Phase 3 Randomized, Double-Masked, Active-Controlled Study of the Efficacy and Safety of 8 MG Aflibercept in Participants with Macular Edema Following Retinal Vein Occlusion
    Regeneron Pharmaceuticals, Inc.
  • A Phase 2, Double Masked, Placebo Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)
    Alexion Pharmaceuticals, Inc.
  • ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
    Novartis Pharmaceuticals Corporation
  • A Phase 2 Randomized, double-masked, active-controlled study to evaluate efficacy and safety of two regimens of BI 771716 against pegcetacoplan in patients with geographic atrophy secondary to age-related macular dege…
    Boehringer Ingelheim International GmbH
  • Phase II PAFRa in GA
    Boehringer Ingelheim International GmbH

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Ophthalmology clinicians in Plantation

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 20, 2026), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1619137320. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.